Evidence map›Paper›PMID 36708564›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2023

Association between the Arg72Pro Genotypes in the TP53 Gene and Ile655Val in the HER2 Gene and the Risk of Developing Breast Cancer in the Population of Amapá, Northern Brazil.

Yasmin Maria Nunes Cardoso, Rafael Lima Resque, Diego Yoshio, Ana Rita B Miranda, Mauro Secco, Artemis Socorro Do N Rodrigues

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yasmin Maria Nunes CardosoMolecular Biology and Biotechnology Laboratory, Federal University of Amapa, Macapá, Amapá, Brazil.ORCID 0000-0003-2877-123X
Rafael Lima ResqueMolecular Biology and Biotechnology Laboratory, Federal University of Amapa, Macapá, Amapá, Brazil.ORCID 0000-0002-5769-5734
Diego YoshioMolecular Biology and Biotechnology Laboratory, Federal University of Amapa, Macapá, Amapá, Brazil.
Ana Rita B MirandaMolecular Biology and Biotechnology Laboratory, Federal University of Amapa, Macapá, Amapá, Brazil.
Mauro SeccoDr. Alberto Lima Hospital of Clinics, Macapá, Amapá, Brazil.ORCID 0000-0002-4540-678X
Artemis Socorro Do N RodriguesMolecular Biology and Biotechnology Laboratory, Federal University of Amapa, Macapá, Amapá, Brazil.ORCID 0000-0002-6345-630X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe polymorphisms Arg72Pro in the TP53 gene (rs1042522) and Ile655Val in the HER2 gene (rs1136201) have been related to susceptibility to several types of cancer. Different studies show the association of these polymorphisms with breast cancer, so our aim in this study was to investigate whether the Arg72Pro and Ile655Val polymorphisms have any influence on the risk of developing breast cancer in women from the city of Macapá, Amapá, located in the brazilian amazon region. METHODS AND

resultsWe then analyzed 80 DNA samples from women with breast cancer and 83 DNA samples from women without the disease, by the Restriction Fragment Length Polymorphism - Polymerase Chain Reaction (PCR-RFLP) technique. The genotype frequencies for rs1042522 were Ar/Arg 23.7%, Arg/Pro 47.5% and Pro/Pro 28.5% in patients and in controls Ar/Arg 69.8%, Arg/Pro 19.2% and Pro/Pro 10.8%. For the HER-2 gene the frequency of Ile/Ile, Ile/Val and Val/Val genotypes was 82.5%, 17.5% and 0% in the patients and 75.9%, 20.4% and 3.6% in the controls. The presence of at least one altered allele in rs1042522 and rs1136201 polymorphisms was found in 91.25% of patient samples.

conclusionThis study found a significant association between the Arg/Pro and Pro/Pro genotypes in the TP53 gene and the Ile/Val genotype in the HER-2 gene and breast cancer risk, however, we emphasize that more studies need to be carried out in the investigated population to consolidate our results.

Indexed as

Breast NeoplasmsBrazilCase-Control StudiesFemaleGenes, erbB-2Genes, p53Genetic Predisposition to DiseaseGenotypeHumansPolymorphism, Single NucleotideRisk FactorsTumor Suppressor Protein p53TP53 protein, humanTumor Suppressor Protein p53breast cancerGene HER-2Gene TP53Macapá Brazil

Identifiers

PMID36708564
PMCPMC10152860

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.